Skip to main content

Advertisement

Log in

Gadolinium-based contrast media exposure and the possible risk of subclinical kidney damage: a pilot study

  • Nephrology - Original Paper
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Purpose

We performed a pilot study to evaluate the feasibility of future research about the presence of subclinical kidney damage after Gadolinium-based contrast media exposure. The future study aims to understand which are the behaviors of two markers of kidney damage, such as urinary NephroCheck (NC) and/or neutrophil gelatinase-associated lipocalin (NGAL). Specifically, after GBCM exposure, NC urinary detection should identify proximal tubule damage while NGAL urinary detection should be related to distal tubule damage.

Methods

We performed a pilot study in patients who had Gadolinium exposure. The feasibility of future study is reached when at least 90% of candidates completed the pilot study. In each patient, we tested urinary NC and NGAL levels 24 h before magnetic resonance imaging (MRI) and 12–24 h after the exposure. Furthermore, we evaluated the administration of other nephrotoxic agents, the presence of comorbidity, and kidney function by S-creatinine and urine protein before the MRI.

Results

We enrolled 35 candidates of whom 33 patients completed all study procedures. Our population had a mean age of 60.7 ± 14.8 years with normal kidney function with a median S-creatinine equal to 0.7 mg/dl (Interquartile range [IQR] 0.6–0.91). Urinary NC levels increased from 0.21 ng2/ml2 (IQR 0.11–0.4) before MRI to 0.34 ng2/ml2 (IQR 0.16–0.86) (p = 0.005). Conversely, we did not appreciate any significant modification in urinary NGAL (p = 0.53).

Conclusion

Our pilot study seems adequate in terms of feasibility and encourages us to focus our future research on renal proximal tubule, as the principal site of subclinical kidney damage after Gadolinium exposure.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Elmståhl B, Leander P, Grant D, Doughty RW, Chai C-M, Björk J et al (2007) Histomorphological changes after renal X-ray arteriography using iodine and gadolinium contrast media in an ischemic porcine model. Acta Radiol. https://doi.org/10.1080/02841850701663442

    Article  PubMed  Google Scholar 

  2. Akgun H, Gonlusen G, Cartwright J Jr, Suki WN, Truong LD (2006) Are gadolinium-based contrast media nephrotoxic? Arch Pathol Lab Med. https://doi.org/10.1043/1543-165(2006)130[1354:AGCMNA]2.0.CO;2

    Article  PubMed  Google Scholar 

  3. Cacheris WP, Quay SC, Rocklage SM (1990) The relationship between thermodynamics and the toxicity of gadolinium complexes. Magn Reson Imaging. https://doi.org/10.1016/0730-725X(90)90055-7

    Article  PubMed  Google Scholar 

  4. Schmidt-Lauber C, Bossaller L, Abujudeh HH, Vladimer GI, Christ A, Fitzgerald KA et al (2015) Gadolinium-based compounds induce NLRP3-dependent IL-1β production and peritoneal inflammation. Ann Rheum Dis. https://doi.org/10.1136/annrheumdis-2013-204900

    Article  PubMed  Google Scholar 

  5. Stutz A, Golenbock DT, Latz E (2009) Inflammasomes: too big to miss. J Clin Invest. https://doi.org/10.1172/JCI40599

    Article  PubMed  PubMed Central  Google Scholar 

  6. Mawad H, Laurin LP, Naud JF, Leblond FA, Henley N, Vallée M et al (2016) Changes in urinary and serum levels of novel biomarkers after administration of gadolinium-based contrast agents. Biomark Insights. https://doi.org/10.4137/BMI.S39199

    Article  PubMed  PubMed Central  Google Scholar 

  7. Spasojević-Dimitrijeva B, Kotur-Stevuljević J, Đukić M, Paripović D, Miloševski-Lomić G, Spasojević-Kalimanovska V et al (2017) Serum neutrophil gelatinase-associated lipocalin and urinary kidney injury molecule-1 as potential biomarkers of subclinical nephrotoxicity after gadolinium-based and iodinated-based contrast media exposure in pediatric patients with normal kidney function. Med Sci Monit. https://doi.org/10.12659/MSM.903255

    Article  PubMed  PubMed Central  Google Scholar 

  8. Kashani K, Al-Khafaji A, Ardiles T, Artigas A, Bagshaw SM, Bell M et al (2013) Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care. https://doi.org/10.1186/cc12503

    Article  PubMed  PubMed Central  Google Scholar 

  9. Price PN, Safirstein RL, Megyesi J (2009) The cell cycle and acute kidney injury. Kidney Int. https://doi.org/10.1038/ki.2009.224

    Article  PubMed  PubMed Central  Google Scholar 

  10. McCullough PA, Shaw AD, Haase M, Bouchard J, Waikar SS, Siew ED et al (2013) Diagnosis of acute kidney injury using functional and injury biomarkers: workgroup statements from the tenth Acute Dialysis Quality Initiative Consensus Conference. Contrib Nephrol. https://doi.org/10.1159/000349963

    Article  PubMed  PubMed Central  Google Scholar 

  11. U.S. Food and Drug Administration. Evaluation of Automatic Class III Designation for NephroCheckSystem® Test System Decision Summary. http://www.accessdata.fda.gov/cdrh_docs/reviews/den130031.pdf

  12. Shang W, Wang Z (2017) The update of NGAL in acute kidney injury. Curr Protein Pept Sci. https://doi.org/10.2174/1389203717666160909125004

    Article  PubMed  Google Scholar 

  13. Schmidt-Ott KM, Mori K, Kalandadze A, Li JY, Paragas N, Nicholas T et al (2006) Neutrophil gelatinase-associated lipocalin-mediated iron traffic in kidney epithelia. Curr Opiom Nephrol Hypertens. https://doi.org/10.1097/01.mnh.0000232886.81142.58

    Article  Google Scholar 

  14. Schmidt-Ott KM (2011) Neutrophil gelatinase-associated lipocalin as biomarker of acute kidney injury—where do we stand today? Nephrol Dial Transpalnt. https://doi.org/10.1093/ndt/gfr006

    Article  Google Scholar 

  15. Andreucci M, Faga T, Pisani A, Perticone M, Michael A (2017) The ischemic/nephrotoxic acute kidney injury and the use of renal biomarkers in clinical practice. Eur J Intern Med. https://doi.org/10.1016/j.ejim.2016.12.001

    Article  PubMed  Google Scholar 

  16. Hertzog MA (2008) Considerations in determining sample size for pilot studies. Res Nurs Health. https://doi.org/10.1002/nur.20247

    Article  PubMed  Google Scholar 

  17. Ortega LM, Heung M (2018) The use of cell cycle arrest biomarkers in the early detection of acute kidney injury. Is this the new renal troponin? Nefrología. 38(4):361–367.https://doi.org/10.1016/j.nefro.2017.11.013

    Article  PubMed  Google Scholar 

  18. Devireddy LR, Hart DO, Goetz DH, Green MR (2010) A mammalian siderophore synthesized by an enzyme with a bacterial homolog involved in enterobactin production. Cell. https://doi.org/10.1016/j.cell.2010.04.040

    Article  PubMed  PubMed Central  Google Scholar 

  19. Bao G, Clifton M, Hoette TM, Mori K, Deng S et al (2010) Iron traffics in circulation bound to a siderocalin (ngal)-catechol complex. J Nat Chem Biol. https://doi.org/10.1038/nchembio.402

    Article  Google Scholar 

  20. Paragas N, Qiu A, Zhang Q, Samstein B, Deng SX, Schmidt-Ott KM et al (2011) The Ngal reporter mouse detects the response of the kidney to injury in real time. Nat Med. https://doi.org/10.1038/nm.2290

    Article  PubMed  PubMed Central  Google Scholar 

  21. Schmidt-Ott KM, Mori K, Li JY, Kalandadze A, Cohen DJ, Devarajan P et al (2007) Dual action of neutrophil gelatinase-associated lipocalin. J Am Soc Nephrol. https://doi.org/10.1681/ASN.2006080882

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The authors wish to thank the physicians and nurses at the Neuroradiology and Radiology Department for their work. Without their support, this work would not have been possible.

Funding

The study did not receive any kind of funding.

Author information

Authors and Affiliations

Authors

Contributions

All the authors have read and approved the final manuscript. Specifically, the authors’ contributions are: guarantors of the integrity of the entire study, FKM and CR; study concepts/study design or data acquisition, all the authors; manuscript drafting or manuscript revision for important intellectual content, all the authors; literature research/statistical analysis/data analysis/interpretation, FKM and GA; manuscript editing, all the authors.

Corresponding author

Correspondence to Francesca Martino.

Ethics declarations

Conflict of interest

CR received compensation and consulted for Astute Medical, OCD, Asahi Medical, Baxter, and Toray Medical. All the other authors have no competing interests.

Ethical approval

The study was approved by the local institutional ethics committee (Resolution number 1449, 25 September 2019). The clinical investigation was conducted according to the principles expressed in the Declaration of Helsinki.

Consent to participate

All the enrolled patients signed informed consent.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Martino, F., Amici, G., Godi, I. et al. Gadolinium-based contrast media exposure and the possible risk of subclinical kidney damage: a pilot study. Int Urol Nephrol 53, 1883–1889 (2021). https://doi.org/10.1007/s11255-020-02779-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-020-02779-2

Keywords

Navigation